Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun;80(6):671-4.
doi: 10.1136/jnnp.2008.152983.

Use of antidepressants and the risk of Parkinson's disease: a prospective study

Affiliations

Use of antidepressants and the risk of Parkinson's disease: a prospective study

A Alonso et al. J Neurol Neurosurg Psychiatry. 2009 Jun.

Abstract

Background: Individuals with depression have a higher risk of Parkinson's disease (PD) but the timing of the association is unknown. Therefore, the relationship between initiation of antidepressant therapy and PD risk was assessed in a large population based database from the UK and the timing of this association was explored.

Methods: A case control study nested in the General Practice Research Database cohort, a large computerised database with clinical information from more than 3 million individuals in the UK, was conducted. Cases of PD were identified from the computer records from 1995 to 2001 and matched with up to 10 controls by age, sex and practice. Use of antidepressants was obtained from the computer records.

Results: 999 PD cases and 6261 controls were included. The rate ratio (RR) and 95% CI of PD in initiators of antidepressant therapy compared with non-initiators was 1.85 (1.25 to 2.75). The association was stronger during the first 2 years after initiation of medication use (RR 2.19; 95% CI 1.38 to 3.46) than later (RR 1.23; 95% CI 0.57 to 2.67). Results were similar for selective serotonin reuptake inhibitors and tricyclic antidepressants separately.

Conclusion: Initiation of any antidepressant therapy was associated with a higher risk of PD in the 2 years after the start of treatment, which suggests that depressive symptoms could be an early manifestation of PD, preceding motor dysfunction.

PubMed Disclaimer

Figures

Figure
Figure
Relative incidence of Parkinson's disease (PD) in initiators versus non-initiators of antidepressant medication according to previous history of depression. General Practice Research Database, United Kingdom

References

    1. Samii A, Nutt JG, Ransom BR. Parkinson's disease. Lancet. 2004;363:1783–93. - PubMed
    1. Ravina B, Camicioli R, Como PG, et al. The impact of depressive symptoms in early Parkinson disease. Neurology. 2007;69:342–7. - PMC - PubMed
    1. Nilsson FM, Kessing LV, Bolwig TG. Increased risk of developing Parkinson's disease for patients with major affective disorders: a register study. Acta Psychiatr Scand. 2001;104:380–6. - PubMed
    1. Schuurman AG, van den Akker M, Ensinck KTJL, et al. Increased risk of Parkinson's disease after depression: A retrospective cohort study. Neurology. 2002;58:1501–4. - PubMed
    1. Brandt-Christensen M, Kvist K, Nilsson FM, et al. Treatment with antidepressants and lithium is associated with increased risk of treatment with antiparkinson drugs: a pharmacoepidemiological study. J Neurol Neurosurg Psychiatr. 2006;77:781–3. - PMC - PubMed

Publication types

MeSH terms

Substances